Johnson & Johnson Total Liabilities 2012-2026 | JNJ

Johnson & Johnson total liabilities for the quarter ending March 31, 2026 were $117.666B, a 8.33% increase year-over-year.

  • Johnson & Johnson total liabilities for 2025 were $117.666B, a 8.33% increase from 2024.
  • Johnson & Johnson total liabilities for 2024 were $108.614B, a 9.95% increase from 2023.
  • Johnson & Johnson total liabilities for 2023 were $98.784B, a 10.66% decline from 2022.

Johnson & Johnson Total Liabilities 2012-2026 | JNJ

  • Johnson & Johnson total liabilities for 2025 were $117.666B, a 8.33% increase from 2024.
  • Johnson & Johnson total liabilities for 2024 were $108.614B, a 9.95% increase from 2023.
  • Johnson & Johnson total liabilities for 2023 were $98.784B, a 10.66% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B